phone iconPhone: (401) 822-4673
phone iconFax: (401) 822-4676
Receive our Health e-Newsletter

News for Healthier Living

Pilot Study Demonstrates Safety of Ifetroban for Patients With High-Risk Solid Tumors, Suggests Potential to Block Cancer Metastasis

Results from a pilot clinical trial conducted by Vanderbilt Health and Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company focused on developing new products for rare diseases, confirm the safety of ifetroban and support the further development of the drug to prevent cancer metastasis.

June 2, 2026


June 11 2026

June 10 2026

June 9 2026

June 8 2026

June 7 2026

June 5 2026

June 4 2026

June 3 2026

June 2 2026

June 1 2026

May 31 2026

May 30 2026

May 29 2026

Angell Street Psychiatry
Copyright 2026 HealthBanks, Inc. All rights reserved.
Terms of Use | Privacy Policy